ORIGINAL ARTICLE

Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2–59 months: a multi-centre, double blind, randomised controlled trial in Pakistan

Tabish Hazir¹, Shamim A Qazi², Yasir Bin Nisar¹, Sajid Maqbool³, Rai Asghar⁴, Imran Iqbal⁵, Sobia Khalid¹, Sajid Randhawa³, Shazia Aslam⁴, Sobia Riaz⁵, Saleem Abbasi¹

¹ Children’s Hospital, Pakistan Institute of Medical Sciences, Islamabad, Pakistan
² Child and Adolescent Health and Development, WHO, Geneva, Switzerland
³ Children’s Hospital, Lahore, Pakistan
⁴ Rawalpindi General Hospital, Rawalpindi, Pakistan
⁵ Nishtar Hospital, Multan, Pakistan

Correspondence to:
Dr Tabish Hazir
ARI Research Cell, Children’s Hospital, Pakistan Institute of Medical Sciences, Islamabad, Pakistan; arichi99{at}ariresearch.edu.pk

Introduction: WHO pneumonia case management guidelines recommend oral amoxicillin as first line treatment for non-severe pneumonia. Increasing treatment failure rates have been reported over a period of time, which could possibly be due to increasing minimum inhibitory concentrations of Streptococcus pneumoniae and Haemophilus influenzae for amoxicillin. Microbiological data show that this resistance can be overcome by increasing amoxicillin dosage. Based on this data, we examined whether we can improve the clinical outcome in non-severe pneumonia by doubling the dose of amoxicillin.

Methods: A double blind randomised controlled trial was conducted in the outpatient departments of four large hospitals in Pakistan. Children aged 2–59 months with non-severe pneumonia were randomised to receive either standard (45 mg/kg/day) or double dose (90 mg/kg/day) oral amoxicillin for 3 days and then followed up for 14 days. Final outcome was treatment failure by day 5.

Results: From September 2003 to June 2004, 876 children completed the study. 437 were randomised to standard and 439 to double dose oral amoxicillin. 20 (4.5%) children in the standard and 25 (5.7%) in the double dose group had therapy failure by day 5. Including the relapses, by day 14 there were 26 (5.9%) cumulative therapy failures with standard and 35 (7.9%) with double dose amoxicillin. These differences were not statistically significant (p = 0.55 and p = 0.29, respectively).

Conclusion: Clinical outcome in children aged 2–59 months with non-severe pneumonia is the same with standard and double dose oral amoxicillin. Non-severe pneumonia can be treated effectively and safely with a 3 day course of a standard dose.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Atoms

Howard Bauchner
Arch. Dis. Child. 2007 92: 283. [Extract] [Full Text] [PDF]

Dealing with childhood pneumonia in developing countries: how can we make a difference?

Zulfiqar A Bhutta
Arch. Dis. Child. 2007 92: 286-288. [Extract] [Full Text] [PDF]

A brief digest of the April issue
Arch. Dis. Child. 2007 92: e4. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Awasthi, S., Agarwal, G., Singh, J. V., Kabra, S. K., Pillai, R. M., Singhi, S., Nongkynrih, B., Dwivedi, R., More, V. B., Kulkarni, M., Niswade, A. K., Bharti, B., Ambast, A., Dhasmana, P., ICMR-IndiaClen Pneumonia Project Group, (2008). Effectiveness of 3-Day Amoxycillin vs. 5-Day Co-trimoxazole in the Treatment of Non-severe Pneumonia in Children Aged 2-59 Months of Age: A Multi-centric Open Labeled Trial. J Trop Pediatr 54: 382-389 [Abstract] [Full Text]  
• (2007). No need to double antibiotic dose in children with non-severe pneumonia. BMJ 334: 1189-1189 [Full Text]  

eLetters:

Read all eLetters

Standard dosage of oral amoxicillin

Theo Fenton, et al.

ADC Online, 12 Apr 2007 [Full text]

Re: Standard dosage of oral amoxicillin

Yasir B Nisar, et al.

ADC Online, 19 Apr 2007 [Full text]